Skip to content

Sofosbuvir/ledipasvir for 8 weeks cures acute HCV in people with HIV

Susanna Naggie presenting at The Liver Meeting 2017. Photo by Liz Highleyman, hivandhepatitis.com

Nivolumab improves outcomes in liver cancer study

Bruno Sangro presenting at The Liver Meeting 2017. Photo by Liz Highleyman, hivandhepatitis.com

Global progress towards hepatitis C elimination still blocked by cost of treatment, lack of diagnosis

UK elimination of hepatitis C in jeopardy unless more patients found

Hepatitis C test-and-treat programme reduces HCV by two-thirds among men who have sex with men in Swiss HIV Cohort

Domizia Salusest | www.domiziasalusest.com

Curing hepatitis C with DAAs linked to 71% reduction in liver cancer

George Iaonnou presenting at The Liver Meeting 2017. Photo by Liz Highleyman, hivandhepatitis.com

High rate of hepatitis C reinfection in German men who have sex with men

High rate of hepatitis C reinfection in German men who have sex with men

Hepatitis C halved in Spanish people living with HIV in one year due to treatment

Juan Berenguer and Juan González from GeSIDA at EACS 2017. Image credit: @GeSIDA

New EACS treatment guidelines

New EACS treatment guidelines